ALX Oncology Holdings Inc.
ALXO
$1.36
$0.043.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 28.55% | 32.00% | 21.77% | 16.14% | -3.50% |
| Total Depreciation and Amortization | -11.10% | -1.18% | 3.82% | 4.31% | 17.85% |
| Total Amortization of Deferred Charges | 6.54% | 5.45% | 5.93% | 6.00% | 13.04% |
| Total Other Non-Cash Items | -20.61% | -1.38% | 9.36% | 15.07% | 9.38% |
| Change in Net Operating Assets | -174.42% | -204.11% | -201.26% | -249.81% | -127.97% |
| Cash from Operations | 24.96% | 22.05% | 22.65% | 6.48% | -16.34% |
| Capital Expenditure | 58.32% | -134.46% | 50.96% | 64.91% | 64.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 183.58% | 382.72% | 196.91% | 88.77% | -49.93% |
| Cash from Investing | 187.13% | 362.57% | 203.20% | 93.15% | -49.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 4.18% | -72.49% | -110.31% | -113.14% | -88.43% |
| Issuance of Common Stock | -99.91% | -99.09% | -97.29% | -96.91% | 9,187.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -97.06% | -96.75% | 2,062.86% | 774.11% | 3,901.83% |
| Cash from Financing | -99.99% | -99.53% | -55.52% | -48.02% | 832.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 310.80% | 116.74% | 113.37% | 81.68% | 88.18% |